Home / Intelligence / Webinars / Ambulatory Surgical Centers: How to Secure Commercial Targeting Success in 2023
Available On Demand
Experts from Trinity Life Sciences’ MedTech team partner with guest speaker, Mayuri Shah from Bain & Co., to deliver insights drawn from real case studies to inform how your organization can strengthen its commercial targeting and engagement strategies for ambulatory surgical centers (ASCs).
Register for this webinar to understand:
- How ASC macrotrends are impacted by market events, procedure type, reimbursement and geography
- How your organization can develop more informed commercial targeting and engagement strategies for ASCs to maximize product adoption, penetration and revenue
- The implications and key considerations for MedTech organizations facing shifting procedures
Head of MedTech
Real World Evidence
Complete the form below to watch the on-demand webinar.
Payer Predictions: Evolution of the U.S. Digital Therapeutics Reimbursement Landscape
Available On Demand
The digital therapeutics (DTx) market is growing rapidly, but a lack of clarity around their reimbursement framework in the U.S. means that there is limited coverage. DTx developers— and pharmaceutical organizations seeking an integrated digital offering— are left to wonder how the payer landscape will evolve as they strategize for the future. Join Trinity Life […]
Surgical Procedures Are Moving to Ambulatory Surgical Centers (ASCs) – or Are They?
For decades, surgical procedures were confined to hospitals where patients would be admitted to the inpatient ward for days, and often weeks, for recovery and monitoring. Increasingly, as technology, technique and safety improved, hospitals began to offer outpatient surgery to patients to drive profitability and an improved patient experience. Most recently, ambulatory surgical centers (ASCs) […]
Reimbursement of Digital Therapeutics in the U.S.
Digital therapeutics (DTx) are impacting how patients are treated, interact with their providers and think about their own health. DTx have garnered interest from the investment community as well as pharma companies seeking an integrated digital offering. However, payers have not yet established a clear framework for integrating these technologies in their plans. Coverage of […]